Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Investors
Resources
Sample Case Studies
Clinical Research Repository
Customer Support
Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Careers
Investors
Resources
Case Studies
Clinical Research Repository
Customer Support
Legal
Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
✕
No results
See all results
2018
June 5, 2019
June 5, 2019
CardieX appendix 4E and 2018 annual financial statements
June 5, 2019
June 5, 2019
Becoming a substantial holder
June 5, 2019
June 5, 2019
Appendix 3B
June 5, 2019
June 5, 2019
CardieX reports successful trial results for wearable sensor
June 5, 2019
June 5, 2019
Form 604 – change in substantial holding
June 5, 2019
June 5, 2019
CardieX restructure and new executive appointments
June 5, 2019
June 5, 2019
CardieX makes first investment in wearable tech partnership
June 5, 2019
June 5, 2019
CardieX commences trading under new code ASX_CDX
June 5, 2019
June 5, 2019
Appendix 3B
Load more
Contact Us
No results
See all results
